Jazz Pharmaceuticals (JAZZ) Director Bruce C. Cozadd Receives RSU Award

What Happened Bruce C. Cozadd, a director of Jazz Pharmaceuticals plc, was granted 1,605 restricted stock units (RSUs) on August 5, 2026. The award was reported at a $0.00 purchase price (code A — award/grant); no cash changed hands at grant. These RSUs convert to one ordinary share each upon vesting, so the economic value will depend on Jazz’s share price at vesting.

Key Details

• Transaction date: 2026-08-05; Form 4 filed: 2026-08-07 (appears timely).
• Grant: 1,605 RSUs @ $0.00 (award, code A).
• Vesting: Units vest in full on July 23, 2027, subject to continuous service and other conditions.
• Plan: Granted under the Issuer’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan (footnote F1).
• Shares owned after transaction: Not disclosed in the provided excerpt.
• Filing status: Not indicated as late in the provided data.

Context RSUs are a form of compensation for directors that convert to shares if vesting conditions are met; this grant is a routine director award rather than an open-market purchase or sale. Because no shares were sold or bought on the open market, the grant itself should be viewed as compensation, not a direct bullish or bearish market signal.